The Asthma Study (Melbourne)
he purpose of this study is to assess the efficacy of an inhaled therapy for asthma patients with moderate to severe persistent asthma that is not controlled by standard of care therapies.
Participants will remain on their current asthma medication (both inhaler and preventer) throughout the study, and their condition and asthma will be carefully monitored throughout the study. The Phase 1 studies have shown to reduce inflammation in the lungs, and so participants could potentially benefit from participating in this study as the medication might improve their asthma status.
**For this study, we are looking for patients with Asthma.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!